The phosphatase inhibitors, orthovanadate and levamisole, inhibit induction of erythroid differentiation and abrogate the associated inhibition of glycolysis

International Journal of Oncology

Volumn 12, Issue 5, 1998, Pages 987-996

  Scher, Barbara M ^a   Fuksina, Inna ^a   Hellinger, Nella ^a   Waxman, Samuel ^a   Scher, William ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Erythroid differentiation; Glycolysis; Levamisole; Orthovanadate; Phosphatase inhibitors

Indexed keywords

LACTIC ACID; LEVAMISOLE; ORTHOVANADIC ACID; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROPOIESIS; GLYCOLYSIS; GROWTH INHIBITION; HEMOGLOBIN DETERMINATION; MOUSE; NONHUMAN; PHOSPHATE METABOLISM; PRIORITY JOURNAL;

EID: 0031966710     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.5.987     Document Type: Article

References (40)

1. Hue L and Rousseau GG: Fructose 2,6-bisphosphate and the control of glycolysis by growth factors, tumor promoters and oncogenes. Adv Enzyme Regul 33: 97-110, 1993.
2. Rousseau GG and Hue L: Mammalian 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a bifunctional enzyme that controls glycolysis. Prog Nucl Acid Res Mol Biol 45: 99-127, 1993.
3. Pilkis SJ: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme. Annu Rev Biochem 64: 799-835, 1995.
4. Scher BM, Chen J, Fuksina I, Waxman S and Scher W: Induction of erythroid differentiation is associated with inhibition of glycolysis and a decrease in fructose 2,6-bisphosphate levels. Int J Oncol 11: 1135-1140, 1997.
5. Darville MI, Antoine IV, Mertens-Strijthagen JR, Dupriez VJ and Rousseau GG: An E2F-dependent late-serum-response promoter in a gene that controls glycolysis. Oncogene 11: 1509-1517, 1995.
6. Kiyokawa H, Richon VM, Rifkind RA and Marks PA: Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol 14: 7195-7203, 1994.
7. Watanabe T, Kume T and Oishi M: Alteration of phosphotyrosine-containing proteins at the early stage of erythroid differentiation of mouse erythroleukemia (MEL) cells. J Biol Chem 267: 17116-17120, 1992.
8. Van Belle H: Alkaline phosphatase. I. Kinetics and inhibition by levamisole of purified isoenzymes from humans. Clin Chem 22: 972-976, 1976.
9. Jing Y and Waxman S: Structural requirements for differentiation-induction and growth-inhibition of mouse erythroleukemia cells by isoflavones. Anticancer Res 15: 1147-1152, 1995.
10. Friend C, Scher W, Holland JG and Sato T: Hemoglobin synthesis in murine virus-induced leukemia cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci USA 68: 378-382, 1971.
11. Ohta Y, Tanaka M, Terada M, Miller OJ, Bank A and Marks PA: Erythroid differentiation: murine erythroleukemia cell variant with unique pattern of induction by polar compounds. Proc Natl Acad Sci USA 73: 1232-1236, 1976.
12. Wu H, Scher BM, Chu LC, Leonard M, Olmedo R, Scher GS, Stecker S, Scher W and Waxman S: Reduction in lactate accumulation correlates with differentiation-induced terminal cell division of leukemia cells. Differentiation 48: 51-58, 1991.
13. Frank DA and Sartorelli AC: Biochemical characterization of tyrosine kinase and phosphotyrosine phosphatase activities of HL-60 leukemia cells. Cancer Res 48: 4299-4306, 1988.
14. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
15. Li H-C, Hsiao K-J and Sampathkumar S: Characterization of a novel alkaline phosphatase activity which co-purifies with a phosphorylase (phosphoprotein) phosphatase of Mr = 35,000 cardiac muscle. J Biol Chem 254: 3368-3374, 1979.
16. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
17. Janssen PAJ: The levamisole story. Prog Drug Res 20: 347-383, 1976.
18. Borgers M and Thoné F: The inhibition of alkaline phosphatase by L-p-bromotetramisole. Histochemistry 44: 277-280, 1975.
19. Lerner U and Granstrom G: Effect of levamisole on bone resorption in cultured mouse calvaria. Eur J Pharmacol 105: 1-14, 1984.
20. Becq F, Jensen TJ, Chang X-B, Savioa A, Rommens JM, Tsui L-C, Buchwald M, Riordan JR and Hanrahan JW: Phosphatase inhibitors activate normal and defective CFTR chloride channels. Proc Natl Acad Sci USA 91: 9160-9164, 1994.
21. Watanabe T, Kume T, Tsuneizumi K, Kondo K, Shiraishi T and Oishi M: Synergistic induction of erythroid differentiation of mouse erythroleukemia (MEL) cell by inhibitors of topoisomerases and protein tyrosine kinases. Exp Cell Res 199: 269-274, 1992.
22. Technical note #10: Problems reported for H7, a widely used protein kinase inhibitor. LC Laboratories 1995 Catalog and Handbook, pp36-38, 1995.
23. Watanabe T, Shiraishi T, Sasaki H and Oishi M: Inhibitors for protein-tyrosine kinases, ST638 and genistein, induce differentiation of mouse erythroleukemia cells in a synergistic manner. Exp Cell Res 183: 335-342, 1989.
24. Coffey Jr RJ, Leof EB, Shipley GD and Moses HL: Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol 132: 143-148, 1987.
25. Li J-P, D'Andrea AD, Lodish HF and Baltimore D: Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 343: 762-764, 1990.
26. Li JP and Baltimore D: Mechanism of leukemogenesis induced by mink cell focus-forming murine leukemia viruses. J Virol 65: 2408-2414, 1991.
27. Kharbanda S, Datta R, Rubin E, Nakamura T, Hass R and Kufe D: Regulation of c-jun expression during induction of monocytic differentiation by okadaic acid. Cell Growth Differ 3: 391-399, 1992.
28. Ben-Baruch N, Reinhold WC, Alexandrova N, Ichinose I, Blake M, Trepel JB and Zajac-Kaye M: c-myc down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation. Mol Pharmacol 46:73-78, 1994.
29. Li H-C, Chernoff J, Chen LB and Kirschenbaum A: A phosphotyrosyl-protein phosphatase activity associated with acid phosphatase from human prostate gland. Eur J Biochem 138: 45-51, 1984.
30. Tonks NK, Diltz CD and Fischer EH: Characterization of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem 263: 6731-6737, 1988.
31. Kume T, Tsuneizumi K, Watanabe T, Thomas ML and Oishi M: Induction of specific protein tyrosine phosphatase transcripts during differentiation of mouse erythroleukemia cells. J Biol Chem 269: 4709-4712, 1994.
32. Gusella J, Weil SC, Tsiftsoglou AS, Volloch V, Neumann JR, Keys C and Housman DE: Hemin does not cause commitment of murine erythroleukemia (MEL) cells to terminal differentiation. Blood 56: 481-487, 1980.
33. Marks PA, Rifkind RA, Bank AM, Terada M, Gambari R, Fibach E, Maniatis G and Reuben R: Expression of globin genes during induced erythroleukemia cell differentiation. In: Cellular and Molecular Regulation of Hemoglobin Switching. Grune and Stratton, New York, pp437-455, 1979.
34. Amery WK and Gough DA: Levamisole and immunotherapy: some theoretic and practical considerations and their relevance to human disease. Oncology 38: 168-181, 1981.
35. Greenspan EM and Erlich R: Levamisole and the new era of chemoimmunotherapy. Cancer Invest 9: 111-124, 1991.
36. Swarup G, Cohen S and Garbera DL: Selective dephosphorylation of proteins containing phosphotyrosine by alkaline phosphatases. J Biol Chem 256: 8197-8201, 1981.
37. Kovach JS, Svingen PA and Schaid DJ: Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase. J Natl Cancer Inst 84: 515-519, 1992.
38. Richon VM, Rifkind RA and Marks PA: Expression of phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells. Cell Growth Differ 3: 413-420, 1992.
39. Zhuo S, Fan S, Huang S and Kaufman S: Study of the role of retinoblastoma protein in terminal differentiation of murine erythroleukemia cells. Proc Natl Acad Sci USA 92: 4234-4238, 1995.
40. Guy CT, Zhou W, Kaufman S and Robinson MO: E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol Cell Biol 16: 685-693, 1996.